1. Home
  2. VC vs SRPT Comparison

VC vs SRPT Comparison

Compare VC & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visteon Corporation

VC

Visteon Corporation

HOLD

Current Price

$118.55

Market Cap

2.6B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.79

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VC
SRPT
Founded
2000
1980
Country
United States
United States
Employees
10000
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
2000
2000

Fundamental Metrics

Financial Performance
Metric
VC
SRPT
Price
$118.55
$17.79
Analyst Decision
Buy
Hold
Analyst Count
13
29
Target Price
$125.50
$25.85
AVG Volume (30 Days)
418.4K
2.6M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
1.39%
N/A
EPS Growth
N/A
N/A
EPS
1.14
2.88
Revenue
$3,768,000,000.00
$2,198,237,000.00
Revenue This Year
$2.39
N/A
Revenue Next Year
$5.21
N/A
P/E Ratio
$103.91
$5.99
Revenue Growth
N/A
15.58
52 Week Low
$81.21
$10.42
52 Week High
$128.32
$43.92

Technical Indicators

Market Signals
Indicator
VC
SRPT
Relative Strength Index (RSI) 65.37 42.49
Support Level $89.59 $17.11
Resistance Level $123.63 $18.10
Average True Range (ATR) 4.09 0.77
MACD 0.20 -0.09
Stochastic Oscillator 88.76 28.85

Price Performance

Historical Comparison
VC
SRPT

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: